Population-based cohorts or disease-based cohorts allow the creation of biobanks that collect large numbers of human samples (which may exceed hundreds of thousands or even millions of samples) and their related data. Samples represent the whole value of research projects. These structures, defined as research infrastructures designed to last for at least several decades, seek robust and cost-effective solutions that preserve the long-term integrity, stability and quality of the samples.
DNAshell® and RNAshell® technologies make it possible to create and develop high-capacity nucleic acid (or their source samples) biobanks, with very low management and operating costs. They are innovative, technologically efficient and economically advantageous solutions for both prospective and retrospective biobanks.